☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Mersana Therapeutics
Mersana Therapeutics Highlighted (UPLIFT) Clinical Trial Results of Upifitamab Rilsodotin for Platinum-Resistant Ovarian Cancer
July 27, 2023
Mersana Therapeutics Reports US FDA’s Partial Clinical Hold on New Patient Enrollment of UpRi for Platinum-Sensitive Ovarian Cance...
June 16, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.